Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RSLS | TMO | ISRG | EW | DXCM |
| Company | Reshape Lifesciences Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Dexcom Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 0.1740 | 567.94 | 368.10 | 87.00 | 132.50 |
| High | 0.1834 | 575.00 | 377.83 | 88.38 | 138.80 |
| Low | 0.1670 | 566.95 | 368.10 | 84.71 | 124.08 |
| Last | 0.1698 | 573.60 | 375.33 | 86.43 | 124.34 |
| Change | -0.0082 | +1.87 | +2.21 | -1.58 | -13.67 |
| % Change | -4.61% | +0.33% | +0.59% | -1.80% | -9.91% |
| Volume | 318,500 | 1,438,100 | 927,800 | 4,979,900 | 8,578,100 |
| 20-Day Average Volume | 308,350 | 1,388,905 | 1,610,910 | 3,132,110 | 2,838,075 |
| Previous Close | 0.1780 | 571.73 | 373.12 | 88.01 | 138.01 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1680 | 567.41 | 380.49 | 90.04 | 135.88 |
| 20-Day Raw Stochastic | 23.14% | 72.91% | 31.46% | 15.61% | 1.45% |
| 20-Day Relative Strength | 48.20% | 52.57% | 46.34% | 43.39% | 41.21% |
| Weighted Alpha | -87.28 | +7.98 | +26.24 | +4.01 | +6.65 |
| Today's Opinion | 72% Sell | 72% Buy | 40% Buy | 40% Buy | 40% Buy |
| Previous Opinion | 64% Sell | 56% Buy | 40% Buy | 56% Buy | 96% Buy |
| Last Month's Opinion | 88% Sell | 80% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.72% since 04/19/24 | +5.29% since 04/19/24 | +2.45% since 04/19/24 | +0.57% since 04/19/24 | -4.87% since 04/19/24 |
| Low | 0.1651 on 04/22/24 | 543.15 on 04/22/24 | 364.31 on 04/22/24 | 84.71 on 04/26/24 | 124.08 on 04/26/24 |
| High | 0.1834 on 04/26/24 | 586.46 on 04/24/24 | 383.62 on 04/24/24 | 89.17 on 04/24/24 | 139.24 on 04/25/24 |
| 1-Month | |||||
| %Chg | -6.70% since 03/26/24 | +0.84% since 03/26/24 | -5.61% since 03/26/24 | -7.48% since 03/26/24 | -11.14% since 03/26/24 |
| Low | 0.1580 on 04/03/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 84.71 on 04/26/24 | 124.08 on 04/26/24 |
| High | 0.2090 on 04/03/24 | 589.93 on 04/09/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 141.99 on 04/09/24 |
| 3-Month | |||||
| %Chg | -17.53% since 01/26/24 | +4.80% since 01/26/24 | +0.15% since 01/26/24 | +18.01% since 01/26/24 | +1.95% since 01/26/24 |
| Low | 0.1414 on 02/14/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 72.71 on 01/29/24 | 113.05 on 02/28/24 |
| High | 0.2245 on 02/20/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| 6-Month | |||||
| %Chg | -23.55% since 10/26/23 | +30.32% since 10/26/23 | +44.63% since 10/26/23 | +37.67% since 10/26/23 | +53.34% since 10/26/23 |
| Low | 0.1414 on 02/14/24 | 420.21 on 10/30/23 | 254.85 on 10/30/23 | 60.57 on 10/30/23 | 84.71 on 10/30/23 |
| High | 0.5900 on 12/13/23 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,230 | 218,951,136 | 133,131,800 | 52,024,552 | 49,241,872 |
| Shares Outstanding, K | 13,135 | 381,714 | 354,706 | 601,927 | 396,026 |
| Annual Sales | 8,680,000 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,622,300,000 |
| Annual Net Income | -11,390,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 541,500,000 |
| Last Quarter Sales | 1,980,000 | 10,886,000,000 | 1,890,600,000 | 1,534,100,000 | 1,034,500,000 |
| Last Quarter Net Income | -1,700,000 | 1,630,000,000 | 544,900,000 | 369,900,000 | 256,300,000 |
| 60-Month Beta | 0.22 | 0.80 | 1.36 | 1.05 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.02 on 11/08/23 | 5.11 on 04/24/24 | 1.50 on 04/18/24 | 0.66 on 04/25/24 | 0.32 on 04/25/24 |
| Latest Earnings Date | 05/20/24 | 04/24/24 | 04/18/24 | 04/25/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.44 | 79.73 | 34.51 | 83.14 |